Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients with HER2-Mutant Non-Small Cell Lung Cancer across Treatment Lines: Evidence from the TRACER/HERTras Real-World Cohort
用户EO9nReo4Hj6s
8天前
32
10
已关闭
DOI:
文献链接:
其他信息:

